Mathew Blackman
Stock Analyst at Stifel
(3.88)
# 589
Out of 4,784 analysts
55
Total ratings
47.5%
Success rate
11.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Initiates: Buy | $25 | $11.71 | +113.49% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $258.75 | +13.24% | 3 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $72.55 | +29.57% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $16.06 | +49.44% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.42 | +111.27% | 1 | Oct 17, 2024 | |
| PEN Penumbra | Initiates: Buy | $238 | $267.56 | -11.05% | 1 | Sep 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $67.74 | +47.62% | 11 | Aug 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $19 → $16 | $10.19 | +57.02% | 5 | Aug 1, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $55 → $60 | $19.28 | +211.20% | 5 | May 29, 2024 | |
| INGN Inogen | Maintains: Hold | $6 → $7 | $6.80 | +2.94% | 12 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9 | $11.97 | -24.81% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $10.64 | +3.38% | 4 | May 10, 2023 |
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $11.71
Upside: +113.49%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $258.75
Upside: +13.24%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $72.55
Upside: +29.57%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $16.06
Upside: +49.44%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.42
Upside: +111.27%
Penumbra
Sep 17, 2024
Initiates: Buy
Price Target: $238
Current: $267.56
Upside: -11.05%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $67.74
Upside: +47.62%
Alphatec Holdings
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $10.19
Upside: +57.02%
Tandem Diabetes Care
May 29, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $19.28
Upside: +211.20%
Inogen
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $6.80
Upside: +2.94%
Mar 13, 2024
Reiterates: Buy
Price Target: $8 → $9
Current: $11.97
Upside: -24.81%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $10.64
Upside: +3.38%